Top 74 Contractors in NAICS 325411: Medicinal and Botanical Manufacturing, FY2024

Parent companies by net contract obligations Oct 1, 2023 – Sep 30, 2024 Code page on GovTribe

The top 10 won 100% of FY2024 NAICS 325411 contract dollars

Ranking facts

Contract obligations
$4,192,027,527 Net of deobligations, by contracts coded NAICS 325411
Contractors
89 Parent companies with an obligation
Largest contractor
Cencora, Inc. $2.94 billion, 70.1% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 74 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $2,939,924,638
Rank history: #2 in FY2021, #2 in FY2022, #2 in FY2023 and #1 in FY2025; up 1 since FY2023.
2
Amerisourcebergen Corporation Through Amerisourcebergen Drug Corp
$1,171,928,314
Rank history: not on the FY2021 list, #4 in FY2022, #1 in FY2023 and not on the FY2025 list; down 1 since FY2023.
3 $30,875,798
Rank history: #3 in FY2021, #3 in FY2022, #4 in FY2023 and #3 in FY2025; up 1 since FY2023.
4 $21,504,323
Rank history: #6 in FY2021, not on the FY2022–FY2023 lists and #2 in FY2025; returned.
5 $6,695,914
Rank history: #5 in FY2021, #6 in FY2022, #6 in FY2023 and #4 in FY2025; up 1 since FY2023.
6 $5,186,280
Rank history: #10 in FY2021, #7 in FY2022, not on the FY2023 list and #16 in FY2025; returned.
7
Meridian Medical Technologies LLC
$2,495,170
Rank history: not on the FY2021–FY2023 lists and #9 in FY2025; new.
8 $2,075,263
Rank history: #7 in FY2021, #8 in FY2022, #8 in FY2023 and #7 in FY2025; unchanged since FY2023.
9 $1,634,132
Rank history: #8 in FY2021, #10 in FY2022, #9 in FY2023 and #5 in FY2025; unchanged since FY2023.
10
Cerilliant Corporation Through Sigma-Aldrich, Inc.
$1,249,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
11 $835,251
Rank history: #11 in FY2021, #16 in FY2022, #12 in FY2023 and #13 in FY2025; up 1 since FY2023.
12 $829,270
Rank history: #14 in FY2021, #37 in FY2022, #10 in FY2023 and not on the FY2025 list; down 2 since FY2023.
13 $741,063
Rank history: #18 in FY2021, not on the FY2022–FY2023 lists and #10 in FY2025; returned.
14 $710,034
Rank history: #34 in FY2021, #25 in FY2022, #15 in FY2023 and #18 in FY2025; up 1 since FY2023.
15 $662,108
Rank history: not on the FY2021–FY2022 lists, #21 in FY2023 and #28 in FY2025; up 6 since FY2023.
16 $529,289
Rank history: not on the FY2021–FY2023 lists and #14 in FY2025; new.
17
Avanti Polar Lipids LLC
$518,671
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
18 $514,508
Rank history: #17 in FY2021, #23 in FY2022, #13 in FY2023 and #11 in FY2025; down 5 since FY2023.
19 $505,913
Rank history: #21 in FY2021, #11 in FY2022, #17 in FY2023 and #21 in FY2025; down 2 since FY2023.
20 $424,940
Rank history: not on the FY2021–FY2023 lists and #6 in FY2025; new.
21 $358,612
Rank history: #29 in FY2021, #26 in FY2022, #20 in FY2023 and #15 in FY2025; down 1 since FY2023.
22 $349,672
Rank history: #19 in FY2021, #24 in FY2022, #24 in FY2023 and #8 in FY2025; up 2 since FY2023.
23 $325,596
Rank history: not on the FY2021–FY2023 lists and #22 in FY2025; new.
24
UIC Parent Corporation Through Curia Global Inc.
$260,609
Rank history: not on the FY2021–FY2022 lists, #16 in FY2023 and #32 in FY2025; down 8 since FY2023.
25
Red One Medical Devices LLC
$240,884
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
26 $238,095
Rank history: #20 in FY2021, #32 in FY2022, #19 in FY2023 and #20 in FY2025; down 7 since FY2023.
27
Sagent Pharmaceuticals Inc. 2 awardees
$220,120
Rank history: #15 in FY2021, #19 in FY2022, #26 in FY2023 and #31 in FY2025; down 1 since FY2023.
28 $217,613
Rank history: #25 in FY2021, #30 in FY2022, #25 in FY2023 and #24 in FY2025; down 3 since FY2023.
29 $209,209
Rank history: #23 in FY2021, #31 in FY2022, #27 in FY2023 and #27 in FY2025; down 2 since FY2023.
30 $150,896
Rank history: #16 in FY2021, #17 in FY2022, #11 in FY2023 and #19 in FY2025; down 19 since FY2023.
31 $144,003
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
32 $140,769
Rank history: not on the FY2021–FY2022 lists, #29 in FY2023 and #30 in FY2025; down 3 since FY2023.
33 $131,046
Rank history: not on the FY2021–FY2023 lists and #25 in FY2025; new.
34 $121,018
Rank history: #62 in FY2021, #48 in FY2022, #56 in FY2023 and not on the FY2025 list; up 22 since FY2023.
35
Bausch & Lomb Incorporated 2 awardees
$82,934
Rank history: #46 in FY2021, #40 in FY2022, #38 in FY2023 and #34 in FY2025; up 3 since FY2023.
36 $70,175
Rank history: #36 in FY2021, #27 in FY2022, #31 in FY2023 and #17 in FY2025; down 5 since FY2023.
37 $66,755
Rank history: not on the FY2021 list, #38 in FY2022, #33 in FY2023 and #33 in FY2025; down 4 since FY2023.
38 $62,996
Rank history: #70 in FY2021, #45 in FY2022, #34 in FY2023 and #37 in FY2025; down 4 since FY2023.
39
Avkare LLC 2 awardees
$56,813
Rank history: #47 in FY2021, #64 in FY2022, #43 in FY2023 and #36 in FY2025; up 4 since FY2023.
40
Integrated Medcraft LLC
$52,471
Rank history: not on the FY2021–FY2022 lists, #51 in FY2023 and not on the FY2025 list; up 11 since FY2023.
41 $48,475
Rank history: not on the FY2021–FY2022 lists, #30 in FY2023 and not on the FY2025 list; down 11 since FY2023.
42 $45,964
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
43 $41,895
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
44 $39,691
Rank history: #42 in FY2021, #46 in FY2022, #42 in FY2023 and #40 in FY2025; down 2 since FY2023.
45 $39,446
Rank history: not on the FY2021–FY2023 lists and #12 in FY2025; new.
46
MR Unlimited LLC
$35,693
Rank history: not on the FY2021–FY2022 lists, #37 in FY2023 and #23 in FY2025; down 9 since FY2023.
47 $32,198
Rank history: #49 in FY2021, not on the FY2022–FY2023 lists and #38 in FY2025; returned.
48
Baxter International Inc. Through Baxter Healthcare Corporation
$31,655
Rank history: #59 in FY2021, #20 in FY2022, #14 in FY2023 and not on the FY2025 list; down 34 since FY2023.
49 $30,000
Rank history: not on the FY2021–FY2022 lists, #39 in FY2023 and not on the FY2025 list; down 10 since FY2023.
50
Bachem Americas Inc.
$28,500
Rank history: not on the FY2021–FY2022 lists, #32 in FY2023 and not on the FY2025 list; down 18 since FY2023.
51 $28,323
Rank history: not on the FY2021–FY2023 lists and #46 in FY2025; new.
52 $24,030
Rank history: not on the FY2021–FY2023 lists and #43 in FY2025; new.
53 $19,800
Rank history: #54 in FY2021, not on the FY2022–FY2023 lists and not on the FY2025 list; returned.
54 $15,486
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
55 $11,979
Rank history: not on the FY2021 list, #62 in FY2022, not on the FY2023 list and #41 in FY2025; returned.
56 $11,300
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
57 $11,210
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
58 $10,820
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
59 $9,800
Rank history: not on the FY2021 list, #52 in FY2022, #47 in FY2023 and #53 in FY2025; down 12 since FY2023.
60 $6,615
Rank history: not on the FY2021–FY2023 lists and #50 in FY2025; new.
61 $5,664
Rank history: not on the FY2021 list, #65 in FY2022, #48 in FY2023 and not on the FY2025 list; down 13 since FY2023.
62 $4,974
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
63
Hikma Pharmaceuticals PLC Through Hikma Pharmaceuticals USA Inc.
$3,414
Rank history: #22 in FY2021, #13 in FY2022, #22 in FY2023 and not on the FY2025 list; down 41 since FY2023.
64 $3,333
Rank history: #1 in FY2021, #1 in FY2022, not on the FY2023 list and #39 in FY2025; returned.
65 $2,731
Rank history: not on the FY2021–FY2022 lists, #44 in FY2023 and #68 in FY2025; down 21 since FY2023.
66
Sanofi Pasteur Inc. Through Sanofi Vaccines US Inc.
$2,580
Rank history: not on the FY2021–FY2023 lists and #62 in FY2025; new.
67 $2,118
Rank history: not on the FY2021–FY2023 lists and #69 in FY2025; new.
68 $1,702
Rank history: not on the FY2021 list, #43 in FY2022, #55 in FY2023 and not on the FY2025 list; down 13 since FY2023.
69
Alvogen Group Inc. Through Alvogen, Inc.
$1,446
Rank history: #72 in FY2021, #63 in FY2022, not on the FY2023 list and not on the FY2025 list; returned.
70 $1,204
Rank history: #77 in FY2021, not on the FY2022–FY2023 lists and #55 in FY2025; returned.
71 $544
Rank history: not on the FY2021–FY2023 lists and #45 in FY2025; new.
72 $522
Rank history: not on the FY2021–FY2023 lists and #56 in FY2025; new.
73
Astrazeneca PLC Through Astrazeneca Pharmaceuticals LP
$500
Rank history: #76 in FY2021, #75 in FY2022, #64 in FY2023 and not on the FY2025 list; down 9 since FY2023.
74
Pacific Star Corporation
$46
Rank history: not on the FY2021–FY2022 lists, #66 in FY2023 and #58 in FY2025; down 8 since FY2023.
Show 49 more

74 of 89 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $4.2 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2024 ran Oct 1, 2023 – Sep 30, 2024. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2023. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2023 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325411 contractors in FY2024?

1. Cencora, Inc. ($2.94B), 2. Amerisourcebergen Corporation ($1.17B), 3. DMS Pharmaceutical Group Inc. ($30.9M), 4. Emergent Biosolutions Inc. ($21.5M), 5. Cardinal Health, Inc. ($6.7M), 6. Patterson Companies, Inc. ($5.19M), 7. Meridian Medical Technologies LLC ($2.5M), 8. Phoenix Textile Corporation ($2.08M), 9. Fresenius Kabi, LLC ($1.63M), 10. Cerilliant Corporation ($1.25M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work